Higher levels of apomorphine and rotigotine prescribing reduce overall secondary healthcare costs in Parkinson's disease-Reference-Cited by-同舟云学术

Higher levels of apomorphine and rotigotine prescribing reduce overall secondary healthcare costs in Parkinson's disease

Published:2016-11 Issue:11 Volume:70 Page:907-915
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Heald A. H.¹,Livingston M.²,Stedman M.³,Wyrko Z.⁴

Affiliation:

1. The School of Medicine and Manchester Academic Health Sciences Centre; University of Manchester; Manchester UK

2. Department of Blood Sciences; Walsall Manor Hospital; Walsall UK

3. RES Consortium; Andover UK

4. University Hospitals Birmingham NHS Foundation Trust; Birmingham UK

Funder

Britannia Pharmaceuticals Limited

Publisher

Hindawi Limited

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ijcp.12844/fullpdf

Reference15 articles.

1. Epidemiology of Parkinson's disease;Lau;Lancet Neurol,2006

2. Cross sectional prevalence survey of idiopathic Parkinson's disease and parkinsonism in London;Schrag;Br Med J,2000

3. Public Health England Public Health Observatory General Practice Profile (For 2011-2013 Age and Gender Profile in Each Practice in Each Year) http://www.apho.org.uk/resource/view.aspx?RID=96724

4. Health and Social Care Information Centre Quality Outcomes Framework (QOF) General Practice Lists (2013-2014) http://www.hscic.gov.uk/qof

5. Late-stage Parkinson disease;Coelho;Neurology,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Device-Aided Therapies in Parkinson’s Disease—Results from the German Care4PD Study;Brain Sciences;2023-04-28

2. Personalised Advanced Therapies in Parkinson’s Disease: The Role of Non-Motor Symptoms Profile;Journal of Personalized Medicine;2021-08-07

3. Cost-Effectiveness of Device-Aided Therapies in Parkinson’s Disease: A Structured Review;Journal of Parkinson's Disease;2021-04-13

4. Dynamics of device-based treatments for Parkinson’s disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa–carbidopa intestinal gel, and deep brain stimulation;Journal of Neural Transmission;2019-06-20

5. Economic Evaluation of Interventions in Parkinson's Disease: A Systematic Literature Review;Movement Disorders Clinical Practice;2019-04